TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
TGTX/Leadership and Strategy
Risk Factors
By Management
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.